BioSpace News Archive

Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), a precision cardiovascular diagnostics company, announced today that it will attend the JP Morgan Healthcare Conference, January 9-12, 2023.

OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced that the Company’s board of directors has approved a 1-for-20 reverse stock split of its shares of common stock.

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, announced that the Company granted stock options to three new employees to purchase an aggregate of 54,400 shares of the Company’s common stock, effective as of January 3, 2023.

Surrozen, Inc., a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, will present on January 12, 2023 at 7:30 a.m. Pacific time at the 41st Annual J.P. Morgan Healthcare Conference.

OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health technology, is unveiling its new U.K. remote patient monitoring service at the 2023 Consumer Electronics Show and setting its sights on the growing Atrial Fibrillation epidemic as the renowned brand reaches its 50th year of heart health leadership.

WuXi Biologics announced a license agreement with GSK plc under which GSK will have exclusive licenses for up to four bi- & multi-specific TCE antibodies developed using WuXi Biologics’ proprietary technology platforms.

YDS Pharmatech, Inc., announced that it is presenting at Biotech Showcase™ 2023.

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that Innova Vascular, Inc. (Innova) has submitted a 510(k) Premarket Notification to the U.S. Food and Drug Administration (FDA) for its thrombectomy devices intended to treat peripheral vascular disease.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th at 4:30 p.m. Pacific Time / 7:30 p.m. Eastern Time in San Francisco, CA.

Medpace Holdings, Inc. announced that it will report its fourth quarter and fiscal year 2022 financial results after the market close on Monday, February 13, 2023.